AU7799198A - Method for preparing pharmaceutical formulation - Google Patents
Method for preparing pharmaceutical formulationInfo
- Publication number
- AU7799198A AU7799198A AU77991/98A AU7799198A AU7799198A AU 7799198 A AU7799198 A AU 7799198A AU 77991/98 A AU77991/98 A AU 77991/98A AU 7799198 A AU7799198 A AU 7799198A AU 7799198 A AU7799198 A AU 7799198A
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical formulation
- preparing pharmaceutical
- preparing
- formulation
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4762897P | 1997-05-23 | 1997-05-23 | |
US60047628 | 1997-05-23 | ||
PCT/US1998/010759 WO1998055106A1 (en) | 1997-05-23 | 1998-05-22 | Method for preparing pharmaceutical formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7799198A true AU7799198A (en) | 1998-12-21 |
Family
ID=21950029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU77991/98A Abandoned AU7799198A (en) | 1997-05-23 | 1998-05-22 | Method for preparing pharmaceutical formulation |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2002501540A (en) |
AU (1) | AU7799198A (en) |
WO (1) | WO1998055106A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001060382A1 (en) | 2000-02-18 | 2001-08-23 | Eisai Co., Ltd. | Micelles |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU660325B2 (en) * | 1991-10-11 | 1995-06-22 | Eisai Co. Ltd. | Anti-endotoxin compounds and related molecules and methods |
WO1994012512A1 (en) * | 1992-11-24 | 1994-06-09 | Daiichi Pharmaceutical Co., Ltd. | Glucosylglucoside derivative |
AU7254396A (en) * | 1995-09-29 | 1997-04-17 | Eisai Research Institute | Method for treating alcoholic liver disease |
JP3944534B2 (en) * | 1996-02-23 | 2007-07-11 | 一雄 阿知波 | Lipid A analog and process for producing the same |
CN1150001C (en) * | 1996-07-03 | 2004-05-19 | 卫材株式会社 | Injections contg. lipid A analogues and process for preparation thereof |
-
1998
- 1998-05-22 AU AU77991/98A patent/AU7799198A/en not_active Abandoned
- 1998-05-22 JP JP50254499A patent/JP2002501540A/en not_active Ceased
- 1998-05-22 WO PCT/US1998/010759 patent/WO1998055106A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
JP2002501540A (en) | 2002-01-15 |
WO1998055106A1 (en) | 1998-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6995396A (en) | Pharmaceutical formulation | |
AU7572196A (en) | Pharmaceutical formulations | |
HUP0100431A3 (en) | Adamantana derivatives, pharmaceutical compositions comprising them and process for preparing them | |
AU7640696A (en) | Thiazolidinedione derivatives, method for preparing the derivatives and pharmaceutical compositions containing same | |
AU1267400A (en) | Pharmaceutical moxifloxacin preparation | |
AU6973396A (en) | Pharmaceutical formulation | |
AU6740298A (en) | Pharmaceutical composition | |
HUP9900056A2 (en) | 4-phenylaminothiazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives | |
AU5336898A (en) | Pharmaceutical composition having high bioavailability and method for preparing it | |
AU5686400A (en) | Method for producing quickly decomposable solid pharmaceutical preparations | |
AU7984198A (en) | Process for preparing hydrofluorocarbons | |
AU8591898A (en) | Pharmaceutical compounds | |
AU696892B2 (en) | Maltitol composition and method for preparing it | |
AU5026599A (en) | A wet granulation method for preparing a stable pharmaceutical formulation | |
AU2620995A (en) | Oxathiolanes, method for their preparation and pharmaceutical compositions containing same | |
AU7582696A (en) | Pharmaceutical formulation | |
AU5817198A (en) | Methods for preparing prenyl alcohol | |
AU9343098A (en) | Pharmaceutical composition | |
AU5737498A (en) | Method for the preparation of alpha-bromo-lactam derivatives | |
AU8031598A (en) | 3-aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them | |
AU1930097A (en) | Slow-release pharmaceutical formulations containing mizolastin | |
AU9363698A (en) | Method for preparing bicycloheptan-amine compounds | |
AU1475595A (en) | Pharmaceutical preparation | |
AU1688099A (en) | Pharmaceutical preparation | |
IL137017A0 (en) | A method for making a pharmaceutical formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |